Sacrospinous Ligament Fixation vs Ischial Spine Fascia Fixation

Sponsor
Peking Union Medical College Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03005613
Collaborator
(none)
76
1
2
47
1.6

Study Details

Study Description

Brief Summary

A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: ischial spine fascia fixation
  • Procedure: sacrospinous ligament fixation
N/A

Detailed Description

Investigational intervention:SSLF or ISFF operations

Study title:A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation.

Principal Investigator:Chang Ren, M.D., Department of Obstetrics & Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College.

Study subjects:Adult patients with symptomatic stage II~IV pelvic organ prolapse will be eligible if all the inclusion criteria are met and without any reason for exclusion.

Study objectives:The primary objective of this study is to assess the short and mid-term efficacy of Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation in treating stage II~ IV pelvic organ prolapse and their recurrence rate as well as their impacts on quality of life.

Study design:Prospective, Single-Blind, Randomized, Clinical Trial

Intervention:

  • ISFF group:Patients receive ISFF according to randomization.

  • SSLF group:Patients receive SSLF according to randomization

Sample size:76 patients (38 in ISFF group, 38 in SSLF group)

Primary endpoint:

•objective success rates at 3 months after operations.

Secondary endpoints:
  • peri-operative parameters .

  • subjective satisfactory rates at 1 year after operations

  • quality of life questionnaires at 1 year after operations

Safety endpoints: complications

Study Design

Study Type:
Interventional
Anticipated Enrollment :
76 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation
Actual Study Start Date :
Jan 1, 2017
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: sacrospinous ligament fixation group

The patients will receive sacrospinous ligament fixation operation.

Procedure: sacrospinous ligament fixation
The participants will receive sacrospinous ligament fixation.

Experimental: ischial spine fascia fixation group

The patients will receive ischial spine fascia fixation operation.

Procedure: ischial spine fascia fixation
The participants will receive ischial spine fascia fixation.

Outcome Measures

Primary Outcome Measures

  1. objective success [3 months after operation]

    no prolapse, stage I or only asymptomatic stage II prolapse

Secondary Outcome Measures

  1. Pelvic Floor Distress Inventory-20 (PFDI-20) [Change from Baseline in PFDI-20 at 3 months and 1 year]

    to evaluate the quality of life in 3 domains

  2. Pelvic Floor Impact Questionnaire-7 (PFIQ-7) [Change from Baseline in PFIQ-7 at 3 months and 1 year]

    to evaluate the quality of life in 3 domains

  3. Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12 (PISQ-12) [Change from Baseline in PISQ-12 at 3 months and 1 year]

    to evaluate the sexual function

  4. complications [through study completion, an average of 1 year]

    peri-operative:massive bleeding, organ injury; post-operative: pelvic hematoma, pain, de novo UI, de novo dyspareunia

  5. recurrence rate [3 months after operation]

    more than asymptomatic stage II prolapse after 3 months

  6. subjective satisfaction ( according to a scale of 5 degrees: significantly worse, worse, no change, improved, greatly improved) [1 year after operation]

    Patient's response as improved or greatly improved

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age≤65 years, for those scheduled to receive hysterectomy age≥40 years

  • patients with symptomatic stage II~IV uterine or vaginal vault prolapse

  • receiving SSLF or ISFF in the gynecological department at Peking Union Medical College Hospital

Exclusion Criteria:
  • plans to live abroad within follow-up span

  • contradiction to these two operations: acute genital infection, narrow vagina (less than two finger-breadth), too-ill to receive operations

  • patients with hip joint problem who could not pose a lithotomy position

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Ob & Gyn, Peking Union Medical College Hospital Beijing Beijing China 100730

Sponsors and Collaborators

  • Peking Union Medical College Hospital

Investigators

  • Principal Investigator: Chang Ren, M.D., Peking Union Medical College Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT03005613
Other Study ID Numbers:
  • RC-H0407-8160061244
First Posted:
Dec 29, 2016
Last Update Posted:
Dec 30, 2019
Last Verified:
Dec 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Peking Union Medical College Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 30, 2019